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EDITORIAL
Massive transfusion and survival in a university hospital
In this volume, the study “Proportion of hemocomponents in 
massive transfusion and its mortality in trauma patients in a 
university hospital” is included. This study documents cus-
tomary transfusion practices in patients who are in a serious 
condition caused by hypovolemic shock admitted to the 
Shock and Trauma Unit of the “Dr. José E. González” Univer-
sity Hospital.
The study is important and comes at the right time for 
different reasons. One of them is the fact that while it is 
infrequent to have detailed researches on transfusion con-
duct in the country, this is even more accurate regarding a 
precise documentation of the use of blood products for 
transfusion support utilized in resuscitation efforts per-
formed during what is known as massive transfusion. Mas-
sive transfusion has different deinitions, employed in the 
literature according to the operative criteria valid in differ-
ent institutions. Among the same it is worth stressing those 
which relect the urgency of subsequent blood replacement: 
replacement of over 50% of estimated blood volume in <3 h 
and the need to transfuse >4 units of red blood cells per 
hour, >5 units in 4 h, or >10 units in 24 h, in general in re-
sponse to a bleeding which may be equal to or larger than 
150 mL/min.1,2
Severe traumatic lesions leading to massive transfusions 
are the main cause of mortality in individuals under 60; 
moreover, trafic accidents constitute the irst cause of mor-
tality in individuals under 30 in developed countries.3 Even 
though severe cranioencephalic traumatism is the most fre-
quent mechanism of death, acute hemorrhage remains the 
number one cause of preventable deaths among this popula-
tion. Amidst the diverse mechanisms which come into play 
in patients with multiple and/or severe traumatism, coagu-
lation system alteration is one of the most important, com-
plex and dificult to correct, either pharmacologically or 
with the restitution of the different coagulation factors 
through blood transfusion. This phenomenon is described as 
“coagulopathy induced by trauma”, and generally occurs in 
1 out of every 4 patients who are admitted to the hospital 
in these conditions, it contributes substantially to the ob-
served morbidity and mortality in this group.4,5
In the study referred to in this number of Medicina Universi-
taria, the workgroup documented clinical, laboratory and 
support factors with blood products —packed red blood cells 
(PRBC) and fresh frozen plasma (FFP)— in a detailed manner 
in order to analyze the effect that the proportion between 
these two hemocomponents had in relation to the inal mea-
surements of the study, survival at 24 h and 30 days after the 
analyzed intervention, in a group of patients who received 
these two products in different proportions. Since the study 
was conducted in a retrospective manner, an intervention 
wasn’t conducted where they introduced a bias of the arbi-
trary use of any of the different guidelines or standard re-
placement scales of intravenous solutions or blood 
components. This allowed documentation of everyday prac-
tice in a hospital with one of the most active shock trauma 
units in the northeast of the country. Up until a few years 
ago the recommended practice, derived from the massive 
transfusion results in patients with hemorrhagic shock as a 
consequence of severe military trauma, was of a FFP pack-
age for every 3 PRBC units.6 In this context, it is necessary to 
remember the loss by consumption of coagulation factors, in 
addition to the effect over functional levels of those who 
have an intravenous infusion of large amounts of crystalloid 
solutions, known as “dilutional coagulopathy”.2,5 Subsequent 
studies suggested that a larger FFP proportion in relation to 
PRBC transfused produced better results, increasing survival 
rates immediately and at 30 days.7,8 The above is controver-
sial due to, among other things, what is known as “survivor 
bias”, because there is evidence that patients who survived 
hemorrhagic shock and massive transfusion suffered from a 
less severe trauma and were able to receive high PRBC/FFP 
rates, than those who died and were not able to receive said 
rate, as a result of their increased severity and lack of time 
for proper resuscitation.7,8
Analyzed data by the authors of the study published in 
this number allow us to observe the variations in everyday 
practice of transfusion support in extreme urgency situa-
tions in an urban hospital center, while follow-up at 30 days 
allowed the survival rate of the group to be determined and 
search for an association of this data with the type and pro-
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portion of both blood products received. There are different 
stands concerning the value of using a certain PRBC/FFP 
proportion; this depends on the fact that restricted use of 
plasma has been linked to a higher mortality, apparently 
caused by a deicient hemostatic resuscitation, while free 
use of this component may be linked to the development of 
infections and different degrees of lung injury.2
In conclusion, the cited study conirms the tendency of 
published data in the last few years in acute trauma and 
hemorrhagic shock literature which ratify transfusion of a 
larger PRBC/FFP proportion as an early treatment measure 
of coagulopathy linked to massive transfusion, which results 
in a substantial improvement in survival rates among this 
segment of the population treated at the hospital. 
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